SEARCH

SEARCH BY CITATION

  • 1
    Dearnaley DP. Additional treatment for pT3 prostate cancer: now, later or never. BJU Int 2007; 100: 9779
  • 2
    Byar DP, Code DK. Hormone therapy for prostate cancer: results of the Veterans Administration Co-operative Urology Research Group. NCI Mongr 1988; 7: 165170
  • 3
    Scherr DS, Pitts WR Jr, Vaughan ED Jr. Diethylstilbestrol revisited: androgen deprivation, osteoporosis and prostate cancer. J Urol 2002; 167: 535
  • 4
    Scherr DS, Pitts WR Jr. Review: The non-steroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer. J Urol 2003; 170: 1703
  • 5
    Pitts WR Jr. The clinical rationale for immediate androgen deprivation without estrogen deprivation. Clin Prostate Cancer 2003; 2: 127